NCT01254318View on ClinicalTrials.gov

Assessment of the Fungal Infection Incidence Across Canada for High Risk Participants With Hematological Disease (P07501)

CompletedOBSERVATIONAL
Enrollment

130

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
MycosesLeukemia
Interventions
OTHER

Standard Care

Health-care interventions will be recorded; no additional procedures outside the standard of care will be required.

All Listed Sponsors
collaborator

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT01254318 - Assessment of the Fungal Infection Incidence Across Canada for High Risk Participants With Hematological Disease (P07501) | Biotech Hunter | Biotech Hunter